William Blair & Company
PRAH

William Blair & Company’s PRA Health Sciences, Inc. PRAH Stock Holding History

William Blair & Company’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,310
Closed -$365K – 1792
2019
Q1 		$365K Hold
3,310
– – ﹤0.01% 1074
2018
Q4 		$304K Sell
3,310
-500
-13% -$50.6K ﹤0.01% 1079
2018
Q3 		$420K Hold
3,810
– – ﹤0.01% 1020
2018
Q2 		$356K Sell
3,810
-805
-17% -$69.3K ﹤0.01% 1054
2018
Q1 		$383K Sell
4,615
-740
-14% -$65.8K ﹤0.01% 1008
2017
Q4 		$488K Buy
5,355
+1,230
+30% +$102K ﹤0.01% 975
2017
Q3 		$314K Hold
4,125
– – ﹤0.01% 1086
2017
Q2 		$309K Buy
+4,125
New +$286K ﹤0.01% 1177

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

William Blair & Company's PRAH Position: Q2 2019 in Review

William Blair & Company sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 3,310 shares — an estimated $365K sold.

William Blair & Company first reported a position in PRAH in Q2 2017 and held it in 8 quarters. The position peaked at $488K in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • William Blair & Company reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • William Blair & Company sold 3,310 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $365K.
  • William Blair & Company first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 8 quarters.
  • William Blair & Company's PRA Health Sciences, Inc. position peaked at $488K in Q4 2017.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on William Blair & Company's 13F filing for Q2 2019, filed 13 Aug 2019.